Back to search

Article

Mucosal Immune Response in BNT162b2 COVID-19 Vaccine Recipients

2021-06-29

Abstract excerpt

Background: Although the BNT162b2 COVID-19 vaccine is known to induce IgG neutralizing antibodies in serum protecting against COVID-19, it has not been studied in detail whether it could generate specific immunity at mucosal sites, which represent the primary route of entry of SARS-CoV-2. <br><br>Methods: Samples of serum and saliva of 60 BNT162b2-vaccinated healthcare workers were collected at baseline, two weeks...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
155b7adc-e36b-5d56-ac5d-8716db54b475
DOI
10.2139/ssrn.3871718
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mucosal Immune Response in BNT162b2 COVID-19 Vaccine RecipientsDOI 10.2139/ssrn.3871718
Select a neighboring publication to make it the new centre.